Ultrasound Infertility Diagnosis and Treatment Market in France (Statistics & Outlook) 2030
The France ultrasound infertility diagnosis and treatment market was valued at $336.54 million in 2020, and is projected to reach $522.36 million by 2030, registering a CAGR of 4.4% from 2021 to 2030. Ultrasound scan is an important part of the diagnosis and treatment of infertility. Ultrasound-guided infertility diagnosis is a technique that is used to determine the cause of fertility in females and males with the help of ultrasound waves. It uses ultrasound waves to detect the details about the pelvic region that comprises ovaries, endometrium, and uterus. It can be used to assess the ovarian reserves, uterine shape & size, and whether the fallopian tubes are open or blocked at a specific site in greater detail.
Infertility is described as the male or female reproductive system's inability to conceive naturally. Fertility services assist both men and women in overcoming infertility. In vitro fertilization, fertility testing, intrauterine insemination, egg freezing, and embryo banking are all examples of fertility procedures. Single mothers, members of the LGBTQ community, and couples who are having difficulty conceiving frequently choose these procedures.
The major factors that drive the growth of France ultrasound infertility diagnosis and treatment market are rise in infertility rate, increase in trend of delayed pregnancies, and rise in number of median age of first-time mothers. In addition, alcohol binging, smoking & tobacco consumption, unhealthy lifestyle, increasing physical & psychological stress, drug use & medication, and environmental & occupational exposure lead to infertility issues, thus driving the growth of the France ultrasound infertility diagnosis and treatment market.
Moreover, rise in prevalence of sexually transmitted infections (STIs) as well as uterine disorders such as endometriosis, fibroids, and polycystic ovarian syndrome (PCOS) leads to infertility issues increase the chances of medically assisted procreation. Furthermore, surge in in vitro fertilization (IVF) due to their success rates and the recent approval by the French Government allowing lesbian couples and single women to access the procedure. Technological advancements in infertility diagnosis and development of minimally invasive procedures for diagnosis such as ultrasound-guided trans-vaginal needle aspiration/biopsy and core-needle testicular biopsy contribute toward the growth of the France ultrasound infertility diagnosis and treatment market.
Increase in overweight and obesity issues among women leads to menstrual disorders and anovulation and are at a higher risk of having a miscarriage or developing fertility issues, which significantly drive the market growth. On the contrary, high cost of infertility diagnosis procedures, risk associated after IVF procedure, and high cost of assisted reproductive technology are anticipated to hinder the France ultrasound infertility diagnosis and treatment market growth during the forecast period.
Impact of COVID-19 Pandemic on Ultrasound Infertility Diagnosis and Treatment Market in France (Pre & Post Analysis)
In addition, the COVID-19 outbreak is anticipated to have a negative impact on the growth of the France ultrasound infertility diagnosis and treatment market. A large number of clinics and hospitals throughout the world were reorganized to boost hospital capacity for COVID-19 patients. Owing to the rapidly increasing COVID-19 cases, non-essential processes faced a possible backlog. Furthermore, the lockdown hampered manufacturing and transportation of crucial hospital supplies.
The infertility diagnostic procedures, embryo transfer procedures (IVF), whether fresh or frozen, suspension of elective surgeries and other non-urgent monitoring treatments were cancelled due to increase in incidence of COVID-19 cases. Moreover, assisted reproductive technology devices & consumables sales temporarily experienced unprecedented losses, as most elective medical procedures were postponed due to the COVID-19 pandemic. However, availability of vaccines and high immunization rate across the nation is expected to increase the infertility diagnostic procedures, thus boosting the France ultrasound infertility diagnosis and treatment market growth.
Furthermore, emerging France ultrasound infertility diagnosis and treatment market are expected to offer potential growth opportunities, due to improved healthcare infrastructure, increase in unmet healthcare needs, and rise in R&D activities.
France ultrasound infertility diagnosis and treatment market segmentation
The France ultrasound infertility diagnosis and treatment market is segmented into care pathway and end user. On the basis of care pathway, the market is segregated into infertility diagnostics, punction, and treatment monitoring. The infertility diagnostics segment is further classified into hysterosonography, hysterosonosalpyngography, and hysterosalpingo-foam sonography (HyFoSy). Furthermore, the punction segment is classified into ultrasound-guided trans-vaginal needle aspiration/biopsy and ultrasound-guided core-needle testicular biopsy. Moreover, the treatment monitoring segment comprises frozen embryo transfer services and ovulation monitoring.
By end user, the France ultrasound infertility diagnosis and treatment market is fragmented into public hospital with infertility department, private fertility clinics, and ambulatory centers and each are further segmented by care pathway into infertility diagnostics, punction, and treatment monitoring.
By Care Pathway
Treatment Monitoring holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Segment review
Depending on the care pathway, the treatment monitoring segment dominated the France ultrasound infertility diagnosis and treatment market in 2020, and is expected to continue this trend during the forecast period.
By end user, the private fertility clinics segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
The key players operating in the France ultrasound infertility diagnosis and treatment market are American Hospital of Paris, Amp Center St Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure, and Ramsay Healthcare Limited (Clinique De La Muette).
By End User
Private Fertility Clinics segment is projected as one of the most lucrative segment.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the France ultrasound infertility diagnosis and treatment market, and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing France ultrasound infertility diagnosis and treatment market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the France ultrasound infertility diagnosis and treatment market.
France Ultrasound Infertility Diagnosis and Treatment Market Report Highlights
| Aspects | Details |
 By CARE PATHWA |
|
 By END USER |
|
 Key Market Players | AMERICAN HOSPITAL 0F PARIS, AMP CENTER ST ROCH, MATERNITÉ DES BLUETS - HOSPITAL PIERRE ROUQUÈS, CENTRE CHIRUGICAL (PIERRE CHEREST CLINIC), AMP NATECIA LYON, POINTGYN - PLEASURE, HOSPITAL GROUP DIACONESSES CROIX SAINT-SIMON, RAMSAY HEALTHCARE LIMITED (CLINIQUE DE LA MUETTE), FERTILITY CENTER-PARSI EAST, HOSPITAL COCHIN |
Analyst Review
This section provides the opinions of the top level CXOs in the France ultrasound infertility diagnosis and treatment market. According to the insights of CXOs, the market is expected to exhibit high growth due to increase in incidence of infertility issues, rise in trend of delayed pregnancies, and technological advancements for determination of infertility diagnosis & treatment monitoring services.
The CXOs further added that increase in smoking & tobacco usage, rise in alcohol consumption, rise in number of overweight & obese individuals, surge in prevalence of sexually transmitted diseases (STDs) lead to infertility disorders among males and females, thus strengthening the market growth.
Moreover, surge in demand for IVF due to its success rates and recent approval of the law in France of allowing single women and lesbians to get fertility treatment and access to medically assisted reproduction, including artificial insemination and IVF are anticipated to boost fertility tourism across the country.
The total market value of France ultrasound infertility diagnosis and treatment market is $336.54 million in 2020.
The forecast period for France ultrasound infertility diagnosis and treatment market is 2021 to 2030
The market value of France ultrasound infertility diagnosis and treatment market in 2021 is $353.03 million.
The base year is 2020 in France ultrasound infertility diagnosis and treatment market
Top companies such as American Hospital of Paris, Amp Center St Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure and Ramsay Healthcare Limited (Clinique De La Muette) held a high market position in 2020.
Treatment monitoring segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period due to surge in utilization of ovulation kits due to their simple usage and lower cost and further technological advancements is expected to drive the segment
Increase in prevalence of fertililty issues, delayed pregnancies and technological advancement in ultrasound infertility diagnosis is anticipated to drive the market in the forecast period.
Loading Table Of Content...
